Global pharma main Lupin acquired approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Prasugrel Tablets USP, five mg and 10 mg, a familiar equal of Effient® Tablets, five mg and 10 mg of Cosette Pharmaceuticals, Inc. The product can be manufactured at Lupin’s facility in Goa, India.
Prasugrel Tablets USP, five mg and 10 mg, (RLD Effient) had expected annual sales of USD 18 million in the US.
Bazaarinformation team has many years of experience, covering the physical and future commodities markets with prominent commodity & equity trading advising which shines further with extensive network to get research from ground levels to generate proper reporting and movements. We are able to get evens out of odds in volatile markets and stockings. ...
